Medical expenditures were higher among individuals with a body mass index (BMI) outside the “healthy weight” range, reflecting the broader health burden associated with both low and high BMI, ...

Please provide your email address to receive an email when new articles are posted on . BMI reduction below 25 kg/m 2 with tirzepatide was linked to improved 10-year ASCVD risk. Lower BMI was also ...